Citigroup »

Amylyx Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9M 575k 3.24
2024-06-30 $1.3M 663k 1.90
2024-03-31 $2.7M 915k 3.00
2023-12-31 $7.7M 531k 14.50
2023-09-30 $2.9M 160k 18.31
2023-03-31 $2.0M 68k 29.34
2022-12-31 $4.3M 116k 36.95
2022-09-30 $5.7M 201k 28.09